Divi’s Labs is in the limelight today after it announced that its Unit-II at village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the USFDA from 10th June 2019 to 15th June, 2019.

This was a general cGMP inspection by the US-FDA.

The inspection has been concluded with no 483 observations.

The stock price has reacted positively to this news and it rose 2.3% to Rs.1561.75, it has come off this intraday high and is now at Rs.1551 levels.